New Delhi, May 20 -- The immensely successful new age weight loss jabs have finally come to India with the recent launch of Eli Lilly's Mounjaro and more are likely to be launched in the due course of time. These drugs couldn't have come at a more critical moment as India is staring down the barrel of a double engine public health crisis of rising cases of diabetes and obesity.

India finds itself in the second spot on a far-from-flattering obesity list. With 180 million, India had a higher incidence of obesity than the USA, which came third with 172 million, as per the Global Burden of Disease Study 2021. China tops that list with 402 million obese adults. Things are only going to get worse, as per a forecasting study published in The La...